<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Activity of antimicrobial agents against anaerobes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Activity of antimicrobial agents against anaerobes</h1>
<div class="graphic"><div class="figure"><div class="ttl">Activity of antimicrobial agents against anaerobes</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup> <colgroup width="70%"></colgroup> <tbody> <tr> <td class="subtitle1">Agent</td> <td class="subtitle1">Comments</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Nearly always active</td> </tr> <tr> <td class="indent1">Metronidazole</td> <td>Limited activity (increased resistance) against microaerophilic streptococci (eg, <em>S. milleri</em>), <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>), and <em>Actinomyces</em> species; bactericidal against most gram-negative anaerobic strains</td> </tr> <tr> <td class="indent1">Carbapenems</td> <td>Resistant to most <em>Bacteroides</em> beta-lactamases, although resistance has been reported<sup>[1,2]</sup></td> </tr> <tr> <td class="indent1">Beta-lactam plus beta-lactamase inhibitors</td> <td>The addition of a beta-lactamase inhibitor to a beta-lactam dramatically increases activity against anaerobes that produce a beta-lactamase</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Variable activity</td> </tr> <tr> <td class="indent1">Clindamycin</td> <td><em>B. fragilis</em> group: 20 to 60% of strains resistant; some Clostridia including <em>C. perfringens</em> are resistant</td> </tr> <tr> <td class="indent1">Cephamycins (Cefoxitin/Cefotetan)</td> <td><em>B. fragilis</em> group: 6 to 44% of strains resistant<sup>[2,3]</sup></td> </tr> <tr> <td class="indent1">Penicillin</td> <td>Inactive against some or most penicillinase-producing anaerobes, including most of the <em>B. fragilis</em> group and many strains of <em>Prevotella melaninogenica</em>, <em>P. intermedia</em>, <em>P. bivia</em>, <em>P. disiens</em>, and some Clostridia, including <em>C. perfringens</em></td> </tr> <tr> <td class="indent1">Other cephalosporins</td> <td>Overall, less activity in vitro than penicillin G against most anaerobes and not recommended for therapy of anaerobic infections</td> </tr> <tr> <td class="indent1">Tetracycline</td> <td>Inactive against many anaerobes and most strains of <em>B. fragilis</em>; doxycycline and minocycline are somewhat more active than tetracycline</td> </tr> <tr> <td class="indent1">Vancomycin</td> <td>Active against gram-positive anaerobes; inactive against gram-negative anaerobes except when given orally where vancomycin greatly diminishes the colon microbiota including <em>B. fragilis</em><sup>[4]</sup></td> </tr> <tr> <td class="indent1">Macrolides</td> <td>Inactive against many <em>Fusobacterium</em> spp and some <em>B. fragilis</em> spp</td> </tr> <tr> <td class="indent1">Fluoroquinolones</td> <td>Not recommended for therapy of anaerobic infections due to increased resistance in <em>Bacteroides</em> spp, including <em>B. fragilis</em> sensu stricto</td> </tr> <tr> <td class="indent1">Tigecycline</td> <td>Active against some anaerobes, including strains of <em>B. fragilis</em> that are resistant to beta-lactams, clindamycin, and quinolones<sup>[2]</sup></td> </tr> <tr> <td class="subtitle2_left" colspan="2">Poor activity</td> </tr> <tr> <td class="indent1">Aminoglycosides</td> <td> </td> </tr> <tr> <td class="indent1">Trimethoprim-sulfamethoxazole</td> <td> </td> </tr> <tr> <td class="indent1">Monobactams (aztreonam)</td> <td> </td> </tr> </tbody></table></div><div class="graphic_reference">References:
<ol>
<li>Ulger Toprak N, Akgul O, Bilgin H, et al. Frequency and associated factors for carbapenem-non-susceptible Bacteroides fragilis group bacteria colonization in hospitalized patients: Case control study in a university hospital in Turkey. Indian J Med Microbiol 2021; 39:518.</li>
<li>Wybo I, Van den Bossche D, Soetens O, et al. Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 2014; 69:155.</li>
<li>Snydman DR, Jacobus NV, McDermott LA, et al. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009. Anaerobe 2017; 43:21.</li>
<li>Edlund C, Barkholt L, Olsson-Liljequist B, Nord CE. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis 1997; 25:729.</li>
</ol></div><div id="graphicVersion">Graphic 73450 Version 15.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
